Endometrial Cancer - PMC

Cancer research · Endometrial cancer · TP53 · ERBB2

While endometrial cancer management remains challenging, a deeper understanding of the genetic diversity as well as the drivers of the various pathogenic states of this disease has led to development of divergent management approaches in an effort to improve therapeutic precision in this complex malignancy.

While endometrial cancer management remains challenging, a deeper understanding of the genetic diversity as well as the drivers of the various pathogenic states of this disease has led to development of divergent management approaches in an effort to improve therapeutic precision in this complex malignancy. This comprehensive review will provide an update on the epidemiology, pathophysiology, diagnosis and molecular classification, recent advancements in disease management, as well important patient quality of life considerations and emerging developments in the rapidly evolving therapeutic landscape of endometrial cancers.

Evidence level: Irányelv / elfogadott gyakorlat. Magas szintű klinikai elfogadottság.

Original source

Related signals